Kim Robert Young
SEC CIK 1971608 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| FDMT | 4D Molecular Therapeutics, Inc. | Chief Medical Off | 7,595 | — | $737.8K | 2 | 2024-02-05 | 2024-02-05 |
Most active insiders at FDMT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kirn David | See Remarks, Dir | — | $4.26M |
| 2 | Bizily Scott | CLO | — | $387.7K |
| 3 | Gupta Ashoo | VP, Fin, Ctrl | — | $6,734 |
| 4 | THEUER CHARLES | Dir | — | — |
Kim Robert Young made no open-market trades at FDMT in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-02-07 | 2024-02-05 | FDMT | 4D Molecular Therapeutics, Inc. | Kim Robert Young | Chief Medical Off | M - OptEx | $15.29 | +24.0K | 7,595 | New | +$366.8K |
| DMT | 2024-02-07 | 2024-02-05 | FDMT | 4D Molecular Therapeutics, Inc. | Kim Robert Young | Chief Medical Off | S - Sale+OE | $30.05 | -24.6K | 1,595 | -94% | -$737.8K |
Purchase Sale Sale after option exercise All abbreviations